An article published in the Bulletin of the World Health Organization (WHO) this month looks at the factors slowing progress in preventing and treating hepatitis B and C infections in Europe. Experts consulted highlight vaccination, voluntary testing, policy development, a focus on high-risk groups like intravenous drug users, standardized data collection, and service integration as…
News: AbbVie and MPP complete licensing agreement to ensure access to G/P in 99 low and middle-income countries
AbbVie and MPP complete a new licensing agreement to ensure access to G/P in 99 low- and middle-income (LMIC) countries and territories
Opinion: Micro-elimination potentially a “big deal” for hep C and HIV services
Following the British HIV Association’s (BHIVA) proposal of ambitious targets for eliminating hepatitis C in people living with HIV in the UK, a new editorial in The Lancet looks at some the benefits of microelimination strategies. “Focusing elimination efforts in smaller affected populations allows for quick, efficient targeting of treatment and prevention services,” the article…
News: Millions flock to free tests as Egypt seeks to eradicate hepatitis C
Reuters published a story this week on a massive campaign to identify and treat patients suffering from hepatitis C infection in Egypt. The aim of the campaign is to screen the entire adult population — or 50 million people — in an attempt to eliminate the disease from the country by 2022. The campaign, Reuters…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 